Laevo-Bambuterol (R-bambuterol) / Alvogen  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Laevo-Bambuterol (R-bambuterol) / Alvogen
ChiCTR2100043100: Pharmacokinetic study of multiple oral administration of R-Bambuterol hydrochloride tablets in a population with higher plasma butylcholinesterase activity

Recruiting
1
50
 
R-BMB 5mg Q24 for 21 days ;R-BMB 5mg QN for 28 days ;R-BMB 10mg QN for 28 days
Dongguan People's Hospital; Key-Pharma Biomedical Inc., Self-finance
Asthma, COPD
 
 

Download Options